Department of Gastroenterology, The Affiliated Wuxi People's Hospital to Nanjing Medical University, 299 Qingyang Road, Wuxi, 214023, Jiangsu, China.
Department of Digestive Endoscopy, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, Jiangsu, China.
BMC Cancer. 2020 Nov 16;20(1):1110. doi: 10.1186/s12885-020-07612-8.
People are at a high risk of gastric cancer if their first-degree relatives suffered from atrophic gastritis (AG), intestinal metaplasia (IM), intraepithelial neoplasia (IEN), dysplasia (DYS), or gastric cancer (GC). This study was performed to analyse the association between FDR-GC and GC precursors.
A cross-sectional study was performed to screen the prevalence of GC precursors from November 2016 to September 2019. A total of 1329 participants with FDR-GC, 193 participants with a family history of non-gastric cancer in FDRs (FDR-nGC), and 860 participants without a family history of cancer in FDRs (FDR-nC) were recruited in this study. The logistic regression model was used in this study.
The prevalence of normal, Non-AG, AG/IM, IEN/DYS, and GC was 31.91, 44.21, 13.81, 8.73, and 1.34%, respectively. The prevalence of IEN/DYS was higher in people with FDR-GC and FDR-nGC (FDR-GC: odds ratio (OR) = 1.655; 95%CI, 1.153-2.376; FDR-nGC: OR = 1.984; 95%CI, 1.122-3.506) than those with FDR-nC. The younger the age at which FDRs were diagnosed with GC, the more likely the participants were to develop AG/IM (P = 0.019). The risk of precursors to GC was higher in participants whose FDR-GC was the mother than in those whose FDR-GC was the father or sibling (OR, non-AG: 1.312 vs. 1.007, 1.274; AG/IM: 1.430 vs. 1.296, 1.378; IEN/DYS: 1.988 vs. 1.573, 1.542). There was no statistically significant difference in non-AG (OR = 1.700; 95%CI, 0.940-3.074), AG/IM (OR = 1.291; 95%CI, 0.579-2.877), and IEN/DYS (OR = 1.265; 95%CI, 0.517-3.096) between participants with one or more FDR-GC.
People with FDR-GC and FDR-nGC are at a high risk of IEN/DYS. When an FDR was diagnosed at a younger age, the risk of AG/IM was higher. The risk of GC precursors was higher in people whose FDR-GC was the mother.
如果一级亲属患有萎缩性胃炎(AG)、肠上皮化生(IM)、上皮内瘤变(IEN)、异型增生(DYS)或胃癌(GC),则人们患胃癌的风险很高。本研究旨在分析家族性胃癌(FDR-GC)与 GC 前体之间的关联。
本研究采用横断面研究方法,于 2016 年 11 月至 2019 年 9 月筛查 GC 前体的患病率。共招募了 1329 名 FDR-GC 患者、193 名 FDR 中无非胃癌家族史的患者(FDR-nGC)和 860 名 FDR 中无癌症家族史的患者(FDR-nC)。本研究采用 logistic 回归模型。
正常、非 AG、AG/IM、IEN/DYS 和 GC 的患病率分别为 31.91%、44.21%、13.81%、8.73%和 1.34%。FDR-GC 和 FDR-nGC 患者 IEN/DYS 的患病率高于 FDR-nC 患者(FDR-GC:比值比(OR)=1.655;95%CI,1.153-2.376;FDR-nGC:OR=1.984;95%CI,1.122-3.506)。FDR 患 GC 的年龄越小,参与者发生 AG/IM 的可能性越大(P=0.019)。与 FDR-GC 为父亲或兄弟姐妹的参与者相比,FDR-GC 为母亲的参与者 GC 前体的风险更高(非 AG:OR,1.312 比 1.007、1.274;AG/IM:OR,1.430 比 1.296、1.378;IEN/DYS:OR,1.988 比 1.573、1.542)。非 AG(OR=1.700;95%CI,0.940-3.074)、AG/IM(OR=1.291;95%CI,0.579-2.877)和 IEN/DYS(OR=1.265;95%CI,0.517-3.096)在具有 1 个或多个 FDR-GC 的参与者之间无统计学差异。
FDR-GC 和 FDR-nGC 患者患 IEN/DYS 的风险较高。当 FDR 的诊断年龄较小,AG/IM 的风险更高。FDR-GC 为母亲的参与者患 GC 前体的风险更高。